Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$96.00 | Xdgrpdp | Pvfgpszjq |
Raising Bio-Techne's Fair Value Estimate Following New Long-Term Targets at Capital Markets Day
Business Strategy and Outlook
Bio-Techne is a market leader in proteins for the pharma, biotech, academic, and diagnostic markets and maintains strong market positioning in antibodies and testing controls for diagnostic partners.